Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
General Neurology
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
e.g. reactive pleiocytosis, in light of publication from
Schimdauer et al in Eur J Neurol 2025 Apr
Related Questions
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
Would you proceed with anti-CD20 treatment in an MS patient who is VZV IgG negative in spite of vaccination in the last year?
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
Are there any precautions that should be taken when transitioning a patient with multiple sclerosis from one disease modifying therapy to another?
What are your vaccine recommendations while patients are on biologics?
How would you approach the decision to escalate DMT in a patient with relapsing multiple sclerosis who has two to three new T2 lesion but no clinical symptoms?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?